According to the Zhitong Finance App, Sinopharm Technology Co., Ltd. (08156) issued an announcement. The board of directors proposed implementing a share merger. The benchmark is the merger of existing shares with a face value of HK$0.0125 per share for every 25 shares of the company's issued and unissued share into consolidated shares with a face value of HK$0.3125 per share. A share merger must wait (including) shareholders' approval in the form of an ordinary resolution at the Extraordinary General Meeting of Shareholders before it can be carried out.
As of the date of this announcement, the current shares are traded on the Stock Exchange in each lot of 5,000 existing shares. After the share merger takes effect, it is recommended that each trading unit traded on the Stock Exchange be changed from 5,000 existing shares to 10,000 merged shares.